ANETA SCHUENEMEYER: Open Payments
NPI 1790774198 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,483 in 127 payments from 17 companies in 2025. Trend: 2023 $2,318 · 2024 $2,178 · 2025 $2,483
Food & beverage: $2,483
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $428 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $328 |
| Neurocrine BioSciences, Inc. | 13 | $327 |
| Janssen Pharmaceuticals, Inc | 8 | $223 |
| Almatica Pharma LLC | 9 | $179 |
| Otsuka America Pharmaceutical, Inc. | 11 | $168 |
| Teva Pharmaceuticals USA, Inc. | 9 | $159 |
| Collegium Pharmaceutical, Inc. | 13 | $143 |
| Noven Therapeutics, LLC | 5 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
Products named: Auvelity, CAPLYTA, INGREZZA, REXULTI, SPRAVATO, LOREEV XR, Jornay PM, Xelstrym.
Industry payments across TX — which companies pay providers there.
